Aaron W. Miller

2.2k total citations · 1 hit paper
63 papers, 1.4k citations indexed

About

Aaron W. Miller is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Aaron W. Miller has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 23 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in Aaron W. Miller's work include Kidney Stones and Urolithiasis Treatments (28 papers), Gut microbiota and health (18 papers) and Urinary Tract Infections Management (16 papers). Aaron W. Miller is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (28 papers), Gut microbiota and health (18 papers) and Urinary Tract Infections Management (16 papers). Aaron W. Miller collaborates with scholars based in United States, Canada and Iran. Aaron W. Miller's co-authors include Manoj Monga, Lamont Wilkins, M. Denise Dearing, Laurie L. Richardson, Colin Dale, Dirk Lange, Kristina L. Penniston, Kevin D. Kohl, Kelly F. Oakeson and David F. Choy and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Aaron W. Miller

57 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining Dysbiosis for a Cluster of Chronic Diseases

2019 233 citations Lamont Wilkins, Manoj Monga et al. Scientific Reports profile →

Peers

Countries citing papers authored by Aaron W. Miller

Since Specialization

Citations

This map shows the geographic impact of Aaron W. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron W. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron W. Miller more than expected).

Fields of papers citing papers by Aaron W. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron W. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron W. Miller. The network helps show where Aaron W. Miller may publish in the future.

Co-authorship network of co-authors of Aaron W. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron W. Miller. A scholar is included among the top collaborators of Aaron W. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron W. Miller. Aaron W. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inducing Oxalobacter formigenes Colonization Reduces Urinary Oxalate in Healthy Adults 2025 ·Kidney International Reports ·Sonia Fargue, Mangesh Suryavanshi, Kyle D. Wood, Joseph J. Crivelli, Robert A. Oster, Dean G. Assimos, Aaron W. Miller, John Knight	1
2	Baseline abundance of oxalate-degrading bacteria determines response to Oxalobacter formigenes probiotic therapy 2025 ·Gut Microbes ·Mangesh Suryavanshi, (unknown), Sonia Fargue, Dean G. Assimos, John Knight, Aaron W. Miller	0
3	MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE 2024 ·The Journal of Urology ·(unknown), (unknown), Hans Adomat, Felipe Eltit, Qiong Wang, (unknown), (unknown), Roman Herout, Rizhi Wang, (unknown), Aaron W. Miller, Ben H. Chew, Dirk Lange	1
4	Cefazolin shifts the kidney microbiota to promote a lithogenic environment 2024 ·Nature Communications ·(unknown), (unknown), (unknown), Jane Nguyen, Leslie A. Bruggeman, Aaron W. Miller	7
5	Mechanism of Nephrolithiasis: Does the Microbiome Play a Role? 2024 ·European Urology Focus ·(unknown), (unknown), Mangesh Suryavanshi, (unknown), (unknown), Aaron W. Miller	1
6	Sacral neuromodulation device biofilm differs in the absence and presence of infection, harbors antibiotic resistance genes, and is reproducible in vitro 2024 ·Neurourology and Urodynamics ·Glenn T. Werneburg, (unknown), (unknown), (unknown), Howard B. Goldman, Raymond R. Rackley, Jacqueline Zillioux, (unknown), (unknown), Daniel A. Shoskes, Aaron W. Miller, Sandip P. Vasavada	2
7	Indwelling Urological Device Biofilm Composition and Characteristics in the Presence and Absence of Infection 2024 ·Urology ·Glenn T. Werneburg, (unknown), Howard B. Goldman, Sandip P. Vasavada, Aaron W. Miller	1
8	Ureteral Stents Harbor Complex Biofilms With Rich Microbiome-Metabolite Interactions 2023 ·The Journal of Urology ·Glenn T. Werneburg, (unknown), Scott D. Lundy, (unknown), Smita De, (unknown), Raymond R. Rackley, Daniel A. Shoskes, Aaron W. Miller	7
9	Biofilms on Indwelling Artificial Urinary Sphincter Devices Harbor Complex Microbe–Metabolite Interaction Networks and Reconstitute Differentially In Vitro by Material Type 2023 ·Biomedicines ·Glenn T. Werneburg, (unknown), (unknown), (unknown), Scott D. Lundy, Kenneth W. Angermeier, Hadley Wood, Bradley C. Gill, Sandip P. Vasavada, Howard B. Goldman, Raymond R. Rackley, Daniel A. Shoskes, Aaron W. Miller	9
10	Local Inflammation But Not Kidney Cell Infection Associated with High APOL1 Expression in COVID-Associated Nephropathy 2023 ·Kidney360 ·Jane Nguyen, Zhenzhen Wu, (unknown), Leal Herlitz, Aaron W. Miller, Leslie A. Bruggeman	4
11	Mechanisms of the intestinal and urinary microbiome in kidney stone disease 2022 ·Nature Reviews Urology ·Aaron W. Miller, Kristina L. Penniston, Kate R. Fitzpatrick, (unknown), Gregory E. Tasian, Dirk Lange	54
12	Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach 2022 ·Urology ·Glenn T. Werneburg, (unknown), Ao Zhang, (unknown), Samuel Haywood, Aaron W. Miller, Eric A. Klein	4
13	Delineating the Role of the Urinary Metabolome in the Lithogenesis of Calcium-Based Kidney Stones 2022 ·Urology ·(unknown), (unknown), (unknown), Lamont Wilkins, Manoj Monga, Aaron W. Miller	5
14	Assessment of the Process Variables for Degradation of Oxalate by Lactobacillus acidophilus ATCC 4356 Using Simulated Rumen Fluid Media and Tea 2020 ·(unknown), Kianoush Khosravi‐Darani, Hedayat Hosseini, (unknown), Aaron W. Miller	6
15	Defining Dysbiosis for a Cluster of Chronic Diseases breakdown → 2019 ·Scientific Reports ·Lamont Wilkins, Manoj Monga, Aaron W. Miller	233
16	Evaluation of Oxalobacter formigenes DSM 4420 biodegradation activity for high oxalate media content: An in vitro model 2019 ·Biocatalysis and Agricultural Biotechnology ·(unknown), Kianoush Khosravi‐Darani, Hedayat Hosseini, Sanaz Tavasoli, Aaron W. Miller	12
17	Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis 2019 ·Kidney International ·Aaron W. Miller, David F. Choy, Kristina L. Penniston, Dirk Lange	79
18	Metagenomic sequencing provides insights into microbial detoxification in the guts of small mammalian herbivores (Neotoma spp.) 2018 ·FEMS Microbiology Ecology ·Kevin D. Kohl, Kelly F. Oakeson, Teri J. Orr, Aaron W. Miller, Jennifer S. Forbey, Caleb D. Phillips, Colin Dale, Robert B. Weiss, M. Denise Dearing	20
19	Aspirin overutilization for the primary prevention of cardiovascular disease 2014 ·Clinical Epidemiology ·Jeffrey J. VanWormer, Aaron W. Miller, Shereif H. Rezkalla	18
20	Development of reusable logic for determination of statin exposure-time from electronic health records 2014 ·Journal of Biomedical Informatics ·Aaron W. Miller, Catherine A. McCarty, Ulrich Broeckel, (unknown), Deanna Cross	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact